BMRN

NASDAQ · Biotechnology

Biomarin Pharmaceutical Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$56.12

-1.01 (-1.77%)

As of Nov 5, 9:48 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 27 77%

Hold 8 23%

Sell 0 0%

Price Target

Analyst Price Target +125.3% upside

Low Target $89.21

Average Target $126.44

High Target $194.19

Current Price $56.12

Current
$56.12

Target
$126.44

$89.21 $126.44 avg $194.19

Scenario Analysis

Bear Case

$89.21

59.0%

Low target

Base Case

$126.44

+125.3%

Avg target

Bull Case

$194.19

+246.0%

High target

Risk/Reward

4.2x

Highly favorable

Price in Context

52-Week High

$70.98

-20.9% from high

52-Week Low

$49.26

+13.9% from low

50-Day SMA

$60.06

-6.6% vs SMA

200-Day SMA

$58.46

-4.0% vs SMA

RSI (14)

53.7

Neutral

Target vs 52W High

$126.44

+78.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-10.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+116.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.2%
MRNA Moderna Inc	Hold	31	35%	$149.45	-38.1%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-60.7%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-35.8%